Clinical features of pericarditis in patients with SARS-CoV-2
Main Article Content
Keywords
Cross-Sectional Studies, Echocardiography, Cardiovascular Diseases, Coronavirus Infections, Pericarditis
Abstract
Background: COVID-19 disease (coronavirus disease 2019) has multiple potentially fatal cardiovascular complications and pericarditis is one of them; however, if prompt treatment is given, fatal events associated to this complication decrease. Its frequency and presentation characteristics are unknown, which is why its early diagnosis is important.
Objective: To know the frequency of pericarditis secondary to COVID-19 and its presentation characteristics.
Material and methods: Cross-sectional study in patients with a diagnosis of pericarditis after COVID-19 disease (with a positive test). Symptoms, age, sex, comorbidities, and electrocardiogram (ECG) and transthoracic echocardiogram (TTE) results were obtained.
Results: A total of 3364 patients positive for COVID-19 were registered, out of which 10 met criteria for pericarditis, which represented a frequency of 0.30%. The average age of the sample was 46.1 years and 60% predominated in the male gender with a 1.5:1 ratio. The most frequent clinical characteristics were the presence of retrosternal pain (90%), absence of comorbidity (50%), and absence of electrocardiographic changes (40%).
Conclusions: Pericarditis has a low frequency in patients with COVID-19. The predominant clinical presentation is chest pain. Almost half will not have electrocardiographic changes, and half will not have comorbidities.
References
Inzunza-Cervantes G, Ornelas-Aguirre JM, Trujillo-García JJ, Peña-Valenzuela AN. Para entender el SARS-CoV-2: un análisis de la pandemia actual. Rev Med Inst Mex Seguro Soc. 2020;58 Supl 2: S164-74. Disponible en: http://revistamedica. imss.gob.mx/editorial/index.php/revista_medica/article/view/ 3673/4166.
Piña-Sánchez P, Monroy-García A, Montesinos JJ, Gutiérrez-de la Barrera M, Vadillo-Rosado EM, Chávez-González MA et al. Biología del SARS CoV 2: hacia el entendimiento y tratamiento de COVID 19. Rev Med Inst Mex Seguro Soc. 2020;58 Supl 2:S194-214. Disponible en: http://revistamedica.imss.gob. mx/editorial/index.php/revista_medica/article/view/3722/4174.
Clemente-Herrera A, Sánchez-De la Torre EJ, Enríquez-Contreras JM. Manifestaciones cardiológicas en pacientes con COVID-19. Med Int Mex. 2020 mayo-junio; 36(3):357-64. doi: 10.24245/mim.v36i3.4229.
López-Ponce de León JD, Cárdenas-Marín PA, Giraldo-González GC, Herrera-Escandón A. Coronavirus – COVID 19: Más allá de la enfermedad pulmonar, qué es y qué sabemos del vínculo con el sistema cardiovascular. Revista Colombiana de Cardiología. 2020;27(3):142-152. doi: 10.1016/j. rccar.2020.04.006.
Blagova O, Varionchik N, Zaidenov V, Savina P, Sarkisova N. Anti-heart antibodies levels and their correlation with clinical symptoms and outcomes in patients with confirmed or suspected diagnosis COVID-19. Eur J Immunol. 2021;51(4):893- 902. doi: 10.1002/eji.202048930.
Núñez-Martínez FJ, Luna-Montalbán R, Orozco-Juárez K, Chávez-Lárraga AJ, Velasco-Santos JI, Verazaluce-Rodríguez BE. Diferencia sodio-cloro como predictor pronóstico en pacientes adultos con diagnóstico de COVID-19. Rev Med Inst Mex Seguro Soc. 2022;60(4):440-6. Disponible en: http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/4547/4415.
Dagrenat C, Sauer F, Jochum G, Uhry S, Heyer H, Keller O, et al. Observational cohort study of pericarditis associated to COVID-19 affection. Archives of Cardiovascular Diseases Supplements. 2021;13(1):165. doi: 10.1016/j. acvdsp.2020.10.348.
Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH, et al. Management of Acute and Recurrent Pericarditis. Journal of the American College of Cardiology. 2020;75(1):76-92. doi: 10.1016/j.jacc.2019.11.021.
Vrettou AR, Parissis J, Ikonomidis I. The Dual Role of Echocardiography in the Diagnosis of Acute Cardiac Complications and Treatment Monitoring for Coronavirus Disease 2019 (COVID-19). Front Cardiovasc Med. 2020;7:129. doi: 10.3389/fcvm.2020.00129.
García-Esquivel MA, Huerta-Liceaga F, Martínez-Garzón LA, Sandoval-Espadas RA, Salame-Khouri L. Infarto agudo al miocardio con elevación del segmento ST en época de COVID-19. Rev Med Inst Mex Seguro Soc. 2020;58 Supl 2:S268-81. Disponible en: http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/3738/4186.
Instituto Mexicano del Seguro Social. Guía de Práctica Clínica Diagnóstico y tratamiento de pericarditis en el adulto. Guía de Evidencias y Recomendaciones. México: IMSS; 29 de junio de 2017. Disponible en: https://www.imss.gob.mx/sites/all/statics/guiasclinicas/463GER.pdf.
Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, et al. Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio. Revista Española de Cardiología. 2015; 68(12):1126.e1-46. doi: 10.1016/j.recesp.2015.10.011.
Buckley BJR, Harrison SL, Fazio-Eynullayeva E, Underhill P, Lane DA, Lip GYH. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur J Clin Invest. 2021 Nov;51(11):e13679. doi: 10.1111/eci.13679.
Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar-Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nature Medicine. 2021;28:1-13. doi: 10.1038/s41591-021-01630-0.
Tung-Chen Y. Acute pericarditis due to COVID-19 infection: An underdiagnosed disease? Med Clin (Engl Ed). 2020;155 (1):44-45. doi: 10.1016/j.medcle.2020.06.001.
Karadeniz H, Yamak BA, Özger HS, Sezenöz B, Tufan A, Emmi G. Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report. Cardiovasc Drugs Ther. 2020;34 (6):883-5. doi: 10.1007/s10557-020-07044-3.
Tung-Chen Y, Blanco-Alonso S, Antón-Huguet B, Figueras-López C, Ugueto-Rodrigo C. Dolor torácico persistente tras resolución de la enfermedad por coronavirus 2019 (COVID-19). Semergen. 2020; 46 Suppl 1:88-90. doi: 10.1016/j. semerg.2020.06.006
Faraj R, Belkhayat C, Bouchlarhem A, El Aidouni G, Bkiyar H, Housni B. Acute pericarditis revealing COVID-19 infection: Case report. Annals of Medicine and Surgery. 2021 Feb;62:225-7. doi: 10.1016/j.amsu.2021.01.053.
Marschall A, Concepción Suárez R, Dejuan Bitriá C, Fernández Pascual MC. Acute pericarditis secondary to COVID-19. Emergencias. 2020;32(3):221-2.
Kumar R, Kumar J, Daly C, Edroos SA. Acute pericarditis as a primary presentation of COVID-19. BMJ Case Reports. 2020; 13(8):e237617. doi: 10.1136/bcr-2020-237617.
Fox K, Prokup JA, Butson K, Jordan K. Acute Effusive Pericarditis: A Late Complication of COVID-19. Cureus. 2020;12 (7):e9074. doi: 10.7759/cureus.9074.
Walker C, Peyko V, Farrell C, Awad-Spirtos J, Adamo M, Scrocco J. Pericardial effusion and cardiac tamponade requiring pericardial window in an otherwise healthy 30-year-old patient with COVID-19: a case report. Journal of Medical Case Reports. 2020;14(1). doi: 10.1186/s13256-020-02467-w.
Asif T, Kassab K, Iskander F, Alyousef T. Acute Pericarditis and Cardiac Tamponade in a Patient with COVID-19: A Therapeutic Challenge. Eur J Case Rep Intern Med. 2020;7(6): 001701. doi: 10.12890/2020_001701.
Sandino Pérez J, Aubert Girbal L, Caravaca-Fontán F, Polanco N, Sevillano Prieto Á, Andrés A. Pericarditis secundaria a infección por COVID-19 en un paciente trasplantado renal. Nefrología. 2021;41(3):349-52. doi: 10.1016/j.nefro.2020.07.003.
Amoozgar B, Kaushal V, Mubashar U, Sen S, Yousaf S, Yotsuya M. Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report. Medicine (Baltimore). 2020;99(37):e22093. doi: 10.1097/ MD.0000000000022093.
Chetrit M, Xu B, Kwon DH, Ramchand J, Rodriguez RE, Tan CD, et al. Imaging-Guided Therapies for Pericardial Diseases. JACC: Cardiovascular Imaging. 2019; 13(6):1422-37. doi: 10.1016/j.jcmg.2019.08.027.
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.